Anand Devaraj
Overview
Explore the profile of Anand Devaraj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
4575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lancaster H, Jiang B, Davies M, Gratama J, Silva M, Yi J, et al.
Eur J Cancer
. 2025 Mar;
220:115324.
PMID: 40022836
Purpose: Artificial intelligence (AI) could reduce lung cancer screening computer tomography (CT)-reading workload if used as a first-reader, ruling-out negative CT-scans at baseline. Evidence is lacking to support AI performance...
2.
Wells A, Walsh S, Adegunsoye A, Cottin V, Danoff S, Devaraj A, et al.
Respir Res
. 2024 Dec;
25(1):448.
PMID: 39741294
Background: We sought consensus among practising respiratory physicians on the prediction, identification and monitoring of progression in patients with fibrosing interstitial lung disease (ILD) using a modified Delphi process. Methods:...
3.
MacLeod M, Knott K, Allinson J, Finney L, Wiseman D, Ritchie A, et al.
Am J Respir Crit Care Med
. 2024 Dec;
PMID: 39680915
Rationale: Unrecognised coronary artery disease (CAD) may contribute to adverse outcomes in chronic obstructive pulmonary disease (COPD). Improved identification of at-risk groups could inform better preventative care. We aimed to...
4.
George P, Rennison-Jones C, Benvenuti G, Sifostratoudaki A, Ottink F, Bou-Zeid W, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39624378
Background: In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used...
5.
Taib A, Au-Yong I, Nair A, Devaraj A, Chen Y, Baldwin D
Br J Radiol
. 2024 Nov;
98(1166):173-179.
PMID: 39563480
The effectiveness of screening programmes is critically dependent on the accuracy of the screening test. Where this relies on clinical expertise, there is an imperative to assure that the level...
6.
Stock C, Nan Y, Fang Y, Kokosi M, Kouranos V, George P, et al.
Rheumatology (Oxford)
. 2024 Oct;
PMID: 39418195
Objectives: Interstitial lung disease (ILD) is the most common cause of death in patients with systemic sclerosis (SSc), although disease behavior is highly heterogeneous. While a usual interstitial pneumonia (UIP)...
7.
Feary J, Devaraj A, Burton M, Chua F, Coker R, Datta A, et al.
Thorax
. 2024 Aug;
79(10):979-981.
PMID: 39107113
Silicosis due to artificial stone (AS) has emerged over the last decade as an increasing global issue. We report the first eight UK cases. All were men; median age was...
8.
Aslani S, Alluri P, Gudmundsson E, Chandy E, McCabe J, Devaraj A, et al.
Comput Med Imaging Graph
. 2024 Jun;
116:102399.
PMID: 38833895
Lung cancer screening (LCS) using annual computed tomography (CT) scanning significantly reduces mortality by detecting cancerous lung nodules at an earlier stage. Deep learning algorithms can improve nodule malignancy risk...
9.
Heriot D, Stock C, Mumtaz Z, Gisli Jenkins R, Chua F, Molyneaux P, et al.
Respirology
. 2024 Mar;
29(5):421-425.
PMID: 38479405
No abstract available.
10.
Devaraj A, Ottink F, Rennison-Jones C, Ble F, Joly O, Azim A, et al.
Am J Respir Crit Care Med
. 2024 Feb;
209(9):1168-1169.
PMID: 38363798
No abstract available.